• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD PHOENIX¿ AST BROTH, 4.5 ML; SEE H.10

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD PHOENIX¿ AST BROTH, 4.5 ML; SEE H.10 Back to Search Results
Catalog Number 246011
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/13/2022
Event Type  malfunction  
Event Description
It was reported that while using the bd phoenix¿ ast broth, 4.5 ml that there was contamination.The following information was provided by the initial reporter: the customer reported two empty tubes and one contaminated tube from lot 2181667.
 
Manufacturer Narrative
Common device name: system, test, automated antimicrobial susceptibility, short incubation.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that while using the bd phoenix¿ ast broth, 4.5 ml that there was contamination.The following information was provided by the initial reporter: the customer reported two empty tubes and one contaminated tube from lot 2181667.
 
Manufacturer Narrative
This complaint is confirmed.This complaint is for contamination and low fill of phoenix ast broth tube (246011) batch 2181667.One tube from the photo was empty, and another was cloudy.Based off the photo, this complaint is confirmed.A review of quality notifications reviewed no quality notifications generated on the complaint batch.A review of complaints revealed no other complaints on this batch.Complaint trending was performed and there are no trends associated with this defect.Bd id/ast will continue to monitor for trends associated with this defect and take action as necessary.The following are guidelines to help minimize phoenix ast issues: media selection isolates must be recovered from non-selective media.See table 16 recommended media in the bd user manual for a list of recommended media.Ensure quality of vendor selection for plated media.Variations in formulations may impact results.Culture handling cultures must be 18-24 hours old for gram-negative & gram-positive organisms and 18-48 hours old for yeast organisms.For qc organisms, ensure organisms have been subcultured at least twice on two consecutive days on proper nonselective media (gram-negative or gram-positive organisms: tsa with 5% sheep blood, yeast: sabouraud dextrose agar).Mcfarland preparation use of a low-quality sterile cotton swab, which shed fibers, could potentially contribute to a falsely high mcfarland reading.Polyester swabs are not recommended.Ensure bd approved nephelometer is adequately calibrated with not expired mcfarland calibration tubes.Prepared tubes should be vortexed for 5 seconds and allowed approximately 10 seconds for air bubbles to surface.Ensure mcfarland falls within proper range of the inoculum density.For 0.5 mcfarland system, 0.50-0.60 is acceptable.For 0.25 mcfarland system, 0.20-0.30 is acceptable.For yeast panels, 2.00-2.40 is acceptable.Confirm current instrument settings for inoculum density before inoculating panels.For example, ensure a 0.50 mcfarland was not prepared for a 0.25 inoculum density instrument setting.Use bacterial suspensions within 60 minutes of preparation.Panel preparation panels should be used within 2 hours of removal from pouch.Inoculate panels within 30 minutes of the time that the ast broth inoculum is prepared.Allow sufficient time for fluid to traverse down the well tracks before moving the panel.Avoid touching the front and backside of the panel.Handle panels by the sides to avoid producing smudges on the surface of the panels.Inoculated panels should be handled with care.Avoid knocking or jarring the panel.Load panels into instrument within 30 minutes of inoculation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHOENIX¿ AST BROTH, 4.5 ML
Type of Device
SEE H.10
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key16060825
MDR Text Key306363262
Report Number1119779-2022-01533
Device Sequence Number1
Product Code LON
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K020321
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date06/28/2023
Device Catalogue Number246011
Device Lot Number2181667
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/30/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-